Light Horse Therapeutics
Biotechnology · Medical AI
Overview
Light Horse is a small molecule drug discovery company that is leading the way in a.
Funding and backers
Backers
2
Mubadala Ventures, Taiho Ventures
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
CrystalsFirst reimagines small-molecule drug discovery. The MAGNET platform integrates structural biology and AI accelerating drug…
Novel therapies for metabolic inflammation and fibrosisThe Elgia team has discovered how metabolic stress drives inflammation and fibrosis…
Warp is the AI-driven U.S. chemistry CRO that turns AI-designed molecules into compounds drug discovery teams can test, in labs built for…
Variational AI is a Canadian technology company founded in 2019 and based in Vancouver. It builds generative models that design small…
Enzymlogic is a world leading analytical CRO for drug discovery with expertise in the kinetic profiling of compounds to facilitate drug…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Taiho VenturesVia a fund
Mubadala VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Light Horse Therapeutics selected by BioSpace as one of the hottest new life sciences companies in the United States for 2026
We are excited to share that BioSpace has selected Light Horse Therapeutics as one of its 15 NextGen: Class of 2026 - top life sciences startups to watch this year.
Read more
Report
Light Horse Therapeutics selected by the American Chemical Society as one of the 10 Start-ups to Watch
We are excited to share that Chemical & Engineering News has selected Light Horse Therapeutics as one of its 10 Start-Ups to Watch. The article explores how our function-first discovery platform scans entire proteins with CRISPR base editing to pinpoint t
Read more
Report
Light Horse Therapeutics Debuts With $62 Million Series A Financing
Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by founding investor Versant Ventures and included Mubadala Capital as well as three strategi
Read more
Report
Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis
SAN DIEGO-(BUSINESS WIRE)-Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class therapeutics using the biotech's pl
Read more
Report
